Amalgamated Bank Cuts Stock Position in Doximity, Inc. (NASDAQ:DOCS)

Amalgamated Bank cut its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 8.1% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 61,705 shares of the company’s stock after selling 5,424 shares during the quarter. Amalgamated Bank’s holdings in Doximity were worth $1,726,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of DOCS. Van ECK Associates Corp grew its position in Doximity by 19.7% during the second quarter. Van ECK Associates Corp now owns 2,590 shares of the company’s stock valued at $72,000 after acquiring an additional 427 shares during the last quarter. Treasurer of the State of North Carolina lifted its stake in Doximity by 1.0% in the fourth quarter. Treasurer of the State of North Carolina now owns 53,128 shares of the company’s stock worth $1,490,000 after purchasing an additional 520 shares during the last quarter. Cornercap Investment Counsel Inc. boosted its position in Doximity by 3.2% during the second quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company’s stock valued at $479,000 after buying an additional 537 shares during the period. Perigon Wealth Management LLC grew its stake in shares of Doximity by 4.5% during the first quarter. Perigon Wealth Management LLC now owns 15,598 shares of the company’s stock valued at $420,000 after buying an additional 676 shares during the last quarter. Finally, Arizona State Retirement System increased its holdings in shares of Doximity by 2.4% in the second quarter. Arizona State Retirement System now owns 30,779 shares of the company’s stock worth $861,000 after buying an additional 725 shares during the period. Institutional investors own 87.19% of the company’s stock.

Analyst Upgrades and Downgrades

DOCS has been the subject of several analyst reports. Barclays increased their target price on Doximity from $31.00 to $35.00 and gave the company an “equal weight” rating in a report on Friday, August 9th. Bank of America lifted their target price on shares of Doximity from $29.00 to $32.00 and gave the stock a “neutral” rating in a research note on Friday, August 9th. Canaccord Genuity Group increased their price target on shares of Doximity from $37.00 to $40.00 and gave the company a “buy” rating in a research report on Tuesday, August 20th. JPMorgan Chase & Co. boosted their price objective on shares of Doximity from $27.00 to $30.00 and gave the company a “neutral” rating in a research report on Monday, August 19th. Finally, Needham & Company LLC raised Doximity from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a research note on Friday, August 9th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $32.42.

Insider Buying and Selling

In other Doximity news, Director Watkin Phoebe L. Yang sold 1,940 shares of Doximity stock in a transaction on Monday, July 29th. The stock was sold at an average price of $28.22, for a total transaction of $54,746.80. Following the completion of the transaction, the director now owns 12,269 shares in the company, valued at $346,231.18. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Watkin Phoebe L. Yang sold 1,011 shares of the company’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $25.54, for a total value of $25,820.94. Following the transaction, the director now owns 11,258 shares in the company, valued at $287,529.32. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Watkin Phoebe L. Yang sold 1,940 shares of the stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $28.22, for a total transaction of $54,746.80. Following the sale, the director now owns 12,269 shares in the company, valued at approximately $346,231.18. The disclosure for this sale can be found here. Insiders have sold 37,951 shares of company stock worth $1,271,018 in the last 90 days. Insiders own 39.40% of the company’s stock.

Doximity Stock Performance

Shares of NASDAQ:DOCS opened at $41.89 on Thursday. Doximity, Inc. has a 52-week low of $19.82 and a 52-week high of $42.02. The firm has a market capitalization of $7.78 billion, a P/E ratio of 58.18, a P/E/G ratio of 5.80 and a beta of 1.27. The stock has a 50 day moving average price of $34.23 and a 200-day moving average price of $29.37.

Doximity (NASDAQ:DOCS) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.06. Doximity had a net margin of 32.53% and a return on equity of 19.26%. The company had revenue of $126.68 million during the quarter, compared to analyst estimates of $119.88 million. On average, equities analysts forecast that Doximity, Inc. will post 0.8 EPS for the current fiscal year.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.